Seeing Is Believing
CALA is currently covered by 2 analysts with an average potential upside of $48.86 (52.01%) from yesterday's end of day stock price of $0.03. Calithera Biosciences activity chart has currently 2 price targets and 8 ratings on display.
Analysts average stock forecasts to be materialized ratio is 62.5% with an average time for these price targets to be met of 73.5 days.
Highest price target for CALA is $7, Lowest price target is $2, average price target is $4.5.
Most recent stock forecast was given by JONATHAN CHANG from LEERINK on 15-Nov-2022. First documented stock forecast 09-Mar-2016.
Currently, out of the existing stock ratings of CALA - 5 which are a Buy (83.33%), 1 which are a Hold (16.67%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
2
$1.97 (6566.67%)
2
1 years 25 days ago
3/3 (100%)
$-0.38 (-15.97%)
79
Hold
8
$7.95 (15900.00%)
1 years 3 months 11 days ago
2/4 (50%)
$39.49 (67.15%)
52
Buy
100
$99.97 (333233.34%)
2 years 11 months 5 days ago
0/1 (0%)
$46 (85.19%)
Buy
340
$339.95 (679900.00%)
240
6 years 8 months 11 days ago
3/3 (100%)
$110.33 (71.65%)
163
What is CALA (Calithera Biosciences) average time for price targets to be met?
Which analyst has the current highest performing score on CALA (Calithera Biosciences) with a proven track record?
Which analyst has the current lower performing score on CALA (Calithera Biosciences) with a proven track record?
Which analyst has the most public recommendations on CALA (Calithera Biosciences)?
Which analyst is the currently most bullish on CALA (Calithera Biosciences)?
Which analyst is the currently most reserved on CALA (Calithera Biosciences)?